THREAD Rare Disease

In particular, rare disease studies are often more complex than other studies because patients and families commonly need to travel long distances to study sites, including overnight travel or even prolonged relocation.

Given 75% rare diseases have childhood onset, rare disease clinical trials involve not only the patient but entire families. DCTs can help mitigate the obstacles to clinical trial participation, opening up access to more families that can benefit from potentially life-changing therapies.

Discover how rare disease clinical studies are ideal candidates for decentralized approaches.